What you should know:
1. Anika designed the product to treat bone voids and other bone defects caused by trauma or age-related degeneration.
2. Dr. Tierney, an orthopedic surgeon at Boston-based New England Baptist Hospital, spoke highly of the therapy, praising its ease of use.
3. Anika designed the therapy to meet the needs of the 900,000 people who have bone voids or bone defects of the knee.
4. Anika will launch the therapy commercially in September.
More articles on biologics:
Laser Spine Institute co-founders now owe ex-business partner $300M+, judge rules
Academic panel to define best practices for outpatient stem cell procedure
The big trends, issues in spine shaping practices today
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
